Data from Phase IIb AIPAC Trial of Eftilagimod Alpha Shows Promise
Immutep reported positive data from the randomized phase IIb AIPAC clinical trial of eftilagimod alpha and paclitaxel in HER2-negative, HR-positive metastatic breast cancer (MBC). (Source: CancerNetwork)
Source: CancerNetwork - April 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
ACS Guidelines for Cancer Surgeries During COVID-19 Epidemic
The American College of Surgeons released guidelines for triaging surgeries of patients with cancer during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - March 31, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Guidelines for Treating Patients with Late-Stage Colorectal Cancer
ASCO released new guidelines for treating patients with late-stage colorectal cancer based on previously existing guidelines using an expert panel. (Source: CancerNetwork)
Source: CancerNetwork - March 31, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Findings Support Screening of COVID-19 in Patients with Cancer
Researchers found that patients with cancer demonstrated deteriorating conditions and poor outcomes from the COVID-19 infection. (Source: CancerNetwork)
Source: CancerNetwork - March 31, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Artificial Intelligence Could Help Predict Tumor Sensitivity for Patients with NSCLC
Researchers determined that artificial intelligence could help predict responses to systemic therapies for patients with non-small cell lung cancer by utilizing CT scans. (Source: CancerNetwork)
Source: CancerNetwork - March 31, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
FDA Approves Durvalumab Plus Standard of Care Chemo for Extensive-Stage SCLC
The FDA approved durvalumab (Imfinzi) as a first-line treatment for adult patients with extensive-stage small cell lung cancer in combination with standard-of-care chemotherapies, etoposide plus either carboplatin or cisplatin. (Source: CancerNetwork)
Source: CancerNetwork - March 30, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19
Researchers from SITC suggested the use of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19. (Source: CancerNetwork)
Source: CancerNetwork - March 30, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Recommendations for Allocating Resources During COVID-19 Pandemic
Researchers outlined a set of 6 recommendations detailing what strategies medical institutions should implement in the event that medical resources become scarce during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - March 30, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Radiation Treatment May Slow Disease Progression for Patients with Prostate Cancer
A recent study analyzed response to treatment of oligometastatic prostate cancer with stereotactic ablative radiotherapy and found improved oncologic outcomes among men. (Source: CancerNetwork)
Source: CancerNetwork - March 30, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Phase I/II Study Shows Promise for Melflufen in Multiple Myeloma
Researchers indicated that these results show the feasibility of this regimen and support the development of additional studies of melflufen in multiple myeloma, both in combination with dexamethasone as well as in triplet regimens. (Source: CancerNetwork)
Source: CancerNetwork - March 29, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Clinical Pathways Lead to Reduction in Spending Within the Oncology Care Model
Researchers suggested that the reduction of drug spending by using value-based clinical pathways to optimize chemotherapy utilization is possible and can increase the chances of a practice ’s success within the Oncology Care Model. (Source: CancerNetwork)
Source: CancerNetwork - March 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Outcomes of the SARS-CoV-2 Infection in Patients with Cancer Treated in China
Researchers reported on the incidence and outcomes of the SARS-CoV-2 infection, which has been linked to COVID-19, in patients with cancer who were treated at a tertiary cancer institution in Wuhan, China. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Trastuzumab Deruxtecan Shows Promise in HER2 Targeted Therapy
A study with a small sample size revealed that trastuzumab deruxtecan showed promising activity in multiple HER2-expressing or HER2-mutant solid tumors. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Outcomes of the SARS-CoV02 Infection in Patients with Cancer Treated in China
Researchers reported on the incidence and outcomes of the SARS-CoV-2 infection, which has been linked to COVID-19, in patients with cancer who were treated at a tertiary cancer institution in Wuhan, China. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Restrictions on Social Activities Delay Epidemic Peak of COVID-19
These projections suggest that premature and sudden lifting of interventions put in place could lead to an earlier secondary peak of COVID-19, which could be flattened by relaxing the interventions gradually. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
